NGEN

NervGen Pharma (NGEN) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov^[3], including 1 Phase 2^[1], 1 Phase 1^[2].

No Form 4 insider filings for NGEN were recorded at the SEC in the past 30 days^[4].